Cargando…
Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy
IMPORTANCE: Facioscapulohumeral muscular dystrophy (FSHD) is considered an autosomal dominant disorder, associated with the deletion of tandemly arrayed D4Z4 repetitive elements. The extensive use of molecular analysis of the D4Z4 locus for FSHD diagnosis has revealed wide clinical variability, sugg...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195625/ https://www.ncbi.nlm.nih.gov/pubmed/32356886 http://dx.doi.org/10.1001/jamanetworkopen.2020.4040 |
_version_ | 1783528573852712960 |
---|---|
author | Ruggiero, Lucia Mele, Fabiano Manganelli, Fiore Bruzzese, Dario Ricci, Giulia Vercelli, Liliana Govi, Monica Vallarola, Antonio Tripodi, Silvia Villa, Luisa Di Muzio, Antonio Scarlato, Marina Bucci, Elisabetta Antonini, Giovanni Maggi, Lorenzo Rodolico, Carmelo Tomelleri, Giuliano Filosto, Massimiliano Previtali, Stefano Angelini, Corrado Berardinelli, Angela Pegoraro, Elena Moggio, Maurizio Mongini, Tiziana Siciliano, Gabriele Santoro, Lucio Tupler, Rossella |
author_facet | Ruggiero, Lucia Mele, Fabiano Manganelli, Fiore Bruzzese, Dario Ricci, Giulia Vercelli, Liliana Govi, Monica Vallarola, Antonio Tripodi, Silvia Villa, Luisa Di Muzio, Antonio Scarlato, Marina Bucci, Elisabetta Antonini, Giovanni Maggi, Lorenzo Rodolico, Carmelo Tomelleri, Giuliano Filosto, Massimiliano Previtali, Stefano Angelini, Corrado Berardinelli, Angela Pegoraro, Elena Moggio, Maurizio Mongini, Tiziana Siciliano, Gabriele Santoro, Lucio Tupler, Rossella |
author_sort | Ruggiero, Lucia |
collection | PubMed |
description | IMPORTANCE: Facioscapulohumeral muscular dystrophy (FSHD) is considered an autosomal dominant disorder, associated with the deletion of tandemly arrayed D4Z4 repetitive elements. The extensive use of molecular analysis of the D4Z4 locus for FSHD diagnosis has revealed wide clinical variability, suggesting that subgroups of patients exist among carriers of the D4Z4 reduced allele (DRA). OBJECTIVE: To investigate the clinical expression of FSHD in the genetic subgroup of carriers of a DRA with 7 to 8 repeat units (RUs). DESIGN, SETTING, AND PARTICIPANTS: This multicenter cross-sectional study included 422 carriers of DRA with 7 to 8 RUs (187 unrelated probands and 235 relatives) from a consecutive sample of 280 probands and 306 relatives from the Italian National Registry for FSHD collected between 2008 and 2016. Participants were evaluated by the Italian Clinical Network for FSHD, and all clinical and molecular data were collected in the Italian National Registry for FSHD database. Data analysis was conducted from January 2017 to June 2018. MAIN OUTCOMES AND MEASURES: The phenotypic classification of probands and relatives was obtained by applying the Comprehensive Clinical Evaluation Form which classifies patients in the 4 following categories: (1) participants presenting facial and scapular girdle muscle weakness typical of FSHD (category A, subcategories A1-A3), (2) participants with muscle weakness limited to scapular girdle or facial muscles (category B, subcategories B1 and B2), (3) asymptomatic or healthy participants (category C, subcategories C1 and C2), and (4) participants with myopathic phenotypes presenting clinical features not consistent with FSHD canonical phenotype (category D, subcategories D1 and D2). RESULTS: A total of 187 probands (mean [SD] age at last neurological examination, 53.5 [15.2] years; 103 [55.1%] men) and 235 relatives (mean [SD] age at last neurologic examination, 45.1 [17.0] years; 104 [44.7%] men) with a DRA with 7 to 8 RUs and a molecular diagnosis of FSHD were evaluated. Of 187 probands, 99 (52.9%; 95% CI, 45.7%-60.1%) displayed the classic FSHD phenotype, whereas 86 (47.1%; 95% CI, 39.8%-54.3%) presented incomplete or atypical phenotypes. Of 235 carrier relatives from 106 unrelated families, 124 (52.8%; 95% CI, 46.4%-59.7%) had no motor impairment, whereas a small number (38 [16.2%; 95% CI, 9.8%-23.1%]) displayed the classic FSHD phenotype, and 73 (31.0%; 95% CI, 24.7%-38.0%) presented with incomplete or atypical phenotypes. In 37 of 106 families (34.9%; 95% CI, 25.9%-44.8%), the proband was the only participant presenting with a myopathic phenotype, while only 20 families (18.9%; 95% CI, 11.9%-27.6%) had a member with autosomal dominant FSHD. CONCLUSIONS AND RELEVANCE: This study found large phenotypic variability associated with individuals carrying a DRA with 7 to 8 RUs, in contrast to the indication that a positive molecular test is the only determining aspect for FSHD diagnosis. These findings suggest that carriers of a DRA with 7 to 8 RUs constitute a genetic subgroup different from classic FSHD. Based on these results, it is recommended that clinicians use the Comprehensive Clinical Evaluation Form for clinical classification and, whenever possible, study the extended family to provide the most adequate clinical management and genetic counseling. |
format | Online Article Text |
id | pubmed-7195625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-71956252020-05-05 Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy Ruggiero, Lucia Mele, Fabiano Manganelli, Fiore Bruzzese, Dario Ricci, Giulia Vercelli, Liliana Govi, Monica Vallarola, Antonio Tripodi, Silvia Villa, Luisa Di Muzio, Antonio Scarlato, Marina Bucci, Elisabetta Antonini, Giovanni Maggi, Lorenzo Rodolico, Carmelo Tomelleri, Giuliano Filosto, Massimiliano Previtali, Stefano Angelini, Corrado Berardinelli, Angela Pegoraro, Elena Moggio, Maurizio Mongini, Tiziana Siciliano, Gabriele Santoro, Lucio Tupler, Rossella JAMA Netw Open Original Investigation IMPORTANCE: Facioscapulohumeral muscular dystrophy (FSHD) is considered an autosomal dominant disorder, associated with the deletion of tandemly arrayed D4Z4 repetitive elements. The extensive use of molecular analysis of the D4Z4 locus for FSHD diagnosis has revealed wide clinical variability, suggesting that subgroups of patients exist among carriers of the D4Z4 reduced allele (DRA). OBJECTIVE: To investigate the clinical expression of FSHD in the genetic subgroup of carriers of a DRA with 7 to 8 repeat units (RUs). DESIGN, SETTING, AND PARTICIPANTS: This multicenter cross-sectional study included 422 carriers of DRA with 7 to 8 RUs (187 unrelated probands and 235 relatives) from a consecutive sample of 280 probands and 306 relatives from the Italian National Registry for FSHD collected between 2008 and 2016. Participants were evaluated by the Italian Clinical Network for FSHD, and all clinical and molecular data were collected in the Italian National Registry for FSHD database. Data analysis was conducted from January 2017 to June 2018. MAIN OUTCOMES AND MEASURES: The phenotypic classification of probands and relatives was obtained by applying the Comprehensive Clinical Evaluation Form which classifies patients in the 4 following categories: (1) participants presenting facial and scapular girdle muscle weakness typical of FSHD (category A, subcategories A1-A3), (2) participants with muscle weakness limited to scapular girdle or facial muscles (category B, subcategories B1 and B2), (3) asymptomatic or healthy participants (category C, subcategories C1 and C2), and (4) participants with myopathic phenotypes presenting clinical features not consistent with FSHD canonical phenotype (category D, subcategories D1 and D2). RESULTS: A total of 187 probands (mean [SD] age at last neurological examination, 53.5 [15.2] years; 103 [55.1%] men) and 235 relatives (mean [SD] age at last neurologic examination, 45.1 [17.0] years; 104 [44.7%] men) with a DRA with 7 to 8 RUs and a molecular diagnosis of FSHD were evaluated. Of 187 probands, 99 (52.9%; 95% CI, 45.7%-60.1%) displayed the classic FSHD phenotype, whereas 86 (47.1%; 95% CI, 39.8%-54.3%) presented incomplete or atypical phenotypes. Of 235 carrier relatives from 106 unrelated families, 124 (52.8%; 95% CI, 46.4%-59.7%) had no motor impairment, whereas a small number (38 [16.2%; 95% CI, 9.8%-23.1%]) displayed the classic FSHD phenotype, and 73 (31.0%; 95% CI, 24.7%-38.0%) presented with incomplete or atypical phenotypes. In 37 of 106 families (34.9%; 95% CI, 25.9%-44.8%), the proband was the only participant presenting with a myopathic phenotype, while only 20 families (18.9%; 95% CI, 11.9%-27.6%) had a member with autosomal dominant FSHD. CONCLUSIONS AND RELEVANCE: This study found large phenotypic variability associated with individuals carrying a DRA with 7 to 8 RUs, in contrast to the indication that a positive molecular test is the only determining aspect for FSHD diagnosis. These findings suggest that carriers of a DRA with 7 to 8 RUs constitute a genetic subgroup different from classic FSHD. Based on these results, it is recommended that clinicians use the Comprehensive Clinical Evaluation Form for clinical classification and, whenever possible, study the extended family to provide the most adequate clinical management and genetic counseling. American Medical Association 2020-05-01 /pmc/articles/PMC7195625/ /pubmed/32356886 http://dx.doi.org/10.1001/jamanetworkopen.2020.4040 Text en Copyright 2020 Ruggiero L et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Original Investigation Ruggiero, Lucia Mele, Fabiano Manganelli, Fiore Bruzzese, Dario Ricci, Giulia Vercelli, Liliana Govi, Monica Vallarola, Antonio Tripodi, Silvia Villa, Luisa Di Muzio, Antonio Scarlato, Marina Bucci, Elisabetta Antonini, Giovanni Maggi, Lorenzo Rodolico, Carmelo Tomelleri, Giuliano Filosto, Massimiliano Previtali, Stefano Angelini, Corrado Berardinelli, Angela Pegoraro, Elena Moggio, Maurizio Mongini, Tiziana Siciliano, Gabriele Santoro, Lucio Tupler, Rossella Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy |
title | Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy |
title_full | Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy |
title_fullStr | Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy |
title_full_unstemmed | Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy |
title_short | Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy |
title_sort | phenotypic variability among patients with d4z4 reduced allele facioscapulohumeral muscular dystrophy |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195625/ https://www.ncbi.nlm.nih.gov/pubmed/32356886 http://dx.doi.org/10.1001/jamanetworkopen.2020.4040 |
work_keys_str_mv | AT ruggierolucia phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT melefabiano phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT manganellifiore phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT bruzzesedario phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT riccigiulia phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT vercellililiana phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT govimonica phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT vallarolaantonio phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT tripodisilvia phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT villaluisa phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT dimuzioantonio phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT scarlatomarina phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT buccielisabetta phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT antoninigiovanni phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT maggilorenzo phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT rodolicocarmelo phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT tomellerigiuliano phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT filostomassimiliano phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT previtalistefano phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT angelinicorrado phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT berardinelliangela phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT pegoraroelena phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT moggiomaurizio phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT monginitiziana phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT sicilianogabriele phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT santorolucio phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy AT tuplerrossella phenotypicvariabilityamongpatientswithd4z4reducedallelefacioscapulohumeralmusculardystrophy |